EUVIMEDEUVIMED entdecken
Crossref

Treatment of ocular sarcoidosis. Study of 65 patients from a series of 342 from a university hospital in northern Spain

Fabricio Benavides-Villanueva, Jorge J Gaitán-Valdizán, Raúl Fernández-Ramón, José L Martín-Varillas, Armin Mobarak, José Cifrián-Martínez, Rosalía Demetrio-Pablo, Santos Castañeda, Ricardo Blanco

International Ophthalmology · 2025

DOI: 10.1007/s10792-025-03629-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2025. Verfasst von Fabricio Benavides-Villanueva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology - Hospital, Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain. Hauptthemen laut MEDLINE: Sarcoidosis, Hospitals, University, Visual Acuity, Glucocorticoids. Die Arbeit nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVES: Ocular involvement in sarcoidosis is a relatively frequent manifestation causing potentially severe complications. Our aim was to evaluate visual outcomes and treatment in a cohort of patients diagnosed with ocular sarcoidosis. METHODS: We conducted a retrospective study of a cohort of 342 patients diagnosed with sarcoidosis according the ATS criteria (compatible clinical, radiological and pathological presentation excluding other granulomatous diseases) from January 1999 to December 2019 in a single university hospital. Ocular manifestations and systemic treatments were assessed: systemic glucocorticoids (GC), conventional synthetic immunosuppressive (csIS) drugs and biological therapy (BT). Best corrected visual acuity (BCVA) according to the different systemic treatments used was compared at diagnosis and after one-year follow-up. RESULTS: Ocular sarcoidosis was observed in 65 of 342 (19%). Main ocular manifestations were uveitis (54; 83.1%), orbital lesions (5; 7.7%), retinal vasculitis (4; 6.2%), dry eye (4; 6.2%) and scleritis (1; 1.5%). Systemic treatment with GC was used in 52 (80%) patients, csIS in 32 (49.2%) and BT in 17 (26.2%) patients. BT was most used in panuveitis (62.5%), posterior uveitis (60%), intermediate uveitis (50%) and retinal vasculitis (50%). Median BCVA at diagnosis was 0.6 [IQR: 0.3-0.8] and 0.9 [0.6-1] at one year later, no significant differences in BCVA were observed between systemic therapies. CONCLUSIONS: In conclusion severe manifestations, like Panuveitis, posterior uveitis, intermediate uveitis and retinal vasculitis required an aggressive treatment. In uveitis, a significant improvement in BCVA was observed after one year of follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcoidosisHospitals, UniversityVisual AcuityGlucocorticoidsImmunosuppressive AgentsEye DiseasesHumansRetrospective StudiesFemaleMaleMiddle AgedAdultSpainAgedFollow-Up StudiesYoung AdultTreatment Outcome

Stichwörter der Autor:innen

Biological therapyRetinal vasculitisSarcoidosisUveitisVisual acuity

Substanzen

GlucocorticoidsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Rheumatology - Hospital, Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain.
  • Department of Ophthalmology - Hospital, Universitario Marqués de Valdecilla, IFIMAV, Avda. Valdecilla S/N, S 39008, Santander, Cantabria, Spain.
  • Department of Rheumatology - Hospital Comarcal de Laredo, IDIVAL, Santander, Cantabria, Spain.
  • Department of Pneumology - Hospital, Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.
  • Department of Rheumatology - Hospital, Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
  • Department of Rheumatology - Hospital, Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain. rblancovela@gmail.com.

Zitieren

APA

Benavides-Villanueva, F., Gaitán-Valdizán, J. J., Fernández-Ramón, R., Martín-Varillas, J. L., Mobarak, A., Cifrián-Martínez, J., Demetrio-Pablo, R., Castañeda, S., & Blanco, R. (2025). Treatment of ocular sarcoidosis. Study of 65 patients from a series of 342 from a university hospital in northern Spain. International Ophthalmology. https://doi.org/10.1007/s10792-025-03629-9

Vancouver

Benavides-Villanueva F, Gaitán-Valdizán JJ, Fernández-Ramón R, Martín-Varillas JL, Mobarak A, Cifrián-Martínez J, et al. Treatment of ocular sarcoidosis. Study of 65 patients from a series of 342 from a university hospital in northern Spain. International Ophthalmology. 2025. doi:10.1007/s10792-025-03629-9

BibTeX
@article{BenavidesVillanueva2025,
  author = {Benavides-Villanueva, Fabricio and Gaitán-Valdizán, Jorge J and Fernández-Ramón, Raúl and Martín-Varillas, José L and Mobarak, Armin and Cifrián-Martínez, José and Demetrio-Pablo, Rosalía and Castañeda, Santos and Blanco, Ricardo},
  title = {Treatment of ocular sarcoidosis. Study of 65 patients from a series of 342 from a university hospital in northern Spain},
  journal = {International Ophthalmology},
  year = {2025},
  doi = {10.1007/s10792-025-03629-9}
}
Kostenlos starten →